RCKT

Rocket Pharmaceuticals, Inc. Common Stock

3.46

USD

RCKT Earnings Reports

Positive Surprise Ratio

RCKT beat 24 of 38 last estimates.

63%

Next Report

Date of Next Report

Feb 25, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.44

Implied change from Q3 25 (Revenue/ EPS)

-2.22%

Implied change from Q4 24 (Revenue/ EPS)

-29.03%

Rocket Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Nov 06, 2025, RCKT reported earnings of -0.45 USD per share (EPS) for Q3 25, beating the estimate of -0.51 USD, resulting in a 12.64% surprise. Revenue reached --, compared to an expected 283.33 thousand, with a -100.00% difference. The market reacted with a -1.86% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 16 analysts forecast an EPS of -0.44 USD, with revenue projected to reach -- USD, implying an decrease of -2.22% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

enGene Holdings Inc. Common Stock

Report Date

Dec 22, 2025 For Q4 25

Estimate

-$0.57

Actual

-$0.73

Surprise

-25.95%

Citius Oncology, Inc. Common Stock

Report Date

Dec 23, 2025 For Q4 25

Estimate

-$0.12

Actual

-$0.06

Surprise

+50.98%

FAQ

What were Rocket Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Rocket Pharmaceuticals, Inc. Common Stock reported EPS of -$0.45, beating estimates by 12.64%, and revenue of $0.00, -100% below expectations.

How did the market react to Rocket Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -1.86%, changed from $3.23 before the earnings release to $3.17 the day after.

When is Rocket Pharmaceuticals, Inc. Common Stock expected to report next?

The next earning report is scheduled for Feb 25, 2026.

What are the forecasts for Rocket Pharmaceuticals, Inc. Common Stock's next earnings report?

Based on 16 analysts, Rocket Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.44 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.